Arzneimittelforschung 2009; 59(12): 659-665
DOI: 10.1055/s-0031-1296456
Antibiotics · Antimycotics · Antiparasitics · Antiviral Drugs · Chemotherapeutics · Cytostatics
Editio Cantor Verlag Aulendorf (Germany)

Synthesis and Antimicrobial Activity of Some Novel Thiazolidine-2,4-dione Derivatives

Arzu Menteşe
1   Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Tandogan, Ankara, (Turkey)
,
Meltem Ceylan-Ünlüsoy
1   Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Tandogan, Ankara, (Turkey)
,
Oya Bozdağ-Dündar
1   Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Tandogan, Ankara, (Turkey)
,
Nurten Altanlar
2   Ankara University, Faculty of Pharmacy, Department of Microbiology, Tandoğan, Ankara, (Turkey)
,
Rahmiye Ertan
1   Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Tandogan, Ankara, (Turkey)
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. Dezember 2011 (online)

Abstract

In this study, a series of phenylefhylsul-fanyl-1,3-thiazolo-thiazolidine-2,4-dione derivatives (VII a –f, VIII a–f) and 5-methyl-[1,2,4] triazolyl-sulfanyl-1,3-fhia-zolo-thiazolidine-2,4-dione derivatives (IXa–f, Xa–f) were synthesized and evaluated for their antibacterial and antifungal activities against S. aureus (ATCC 25923), methicillin resistant S. aureus (MRSA ATCC 43300), B. subtilis (ATCC 6633), E. coli (ATCC 23556) and C. albicans (ATCC10145). All the compounds were found active against used bacteria.

 
  • References

  • 1 Todar K. Todar’s online textbook of bacteriology [Internet]. Madison (WI): University of Wisconsin, Department of Bacteriology; c 2008. [cited 2009 July 30]. Available from: www.textbookofbacteriology.net
  • 2 Hooper DC. Minimizing potential resistance: The molecular view-A comment on Courvalin and Trieu-Cuot. Clin Infect Dis. 2001; 33: 157-60
  • 3 Galimand M, Courvalin P, Lambert T. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteria-ceae due to 16S rRNA methylation. Antimicrob Agents Chemother. 2003; 47: 2565-71
  • 4 Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2002; 46: 2727-34
  • 5 Nagai K, Davies TA, Jacobs MR, Appelbaum PC. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1 a, 2 b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant Pneumococci. Antimicrob Agents Chemother. 2002; 46: 1273-80
  • 6 Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006; 119: 3-10
  • 7 Fung-Tomc JC, Clark J, Minassian B, Pucci M, Tsai YH, Gradelski E et al. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible Staphylococci. Antimicrob Agents Chemother. 2002; 46: 971-6
  • 8 Chopra I. Glycylcyclines: third-generation tetracycline antibiotics. Curr Opin Pharmacol. 2001; 1: 464-9
  • 9 Nagano R, Shibata K, Adachi Y, Imamura H, Hashizume T, Morishima H. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-lβ-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa . Antimicrob Agents Chemother. 2000; 44: 489-95
  • 10 Capobianco JO, Cao Z, Shortridge VD, Ma Z, Flamm RK, Zhong P. Studies of the Novel Ketolide ABT-773: Transport, Binding to Ribosomes, and Inhibition of Protein Synthesis in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2000; 44: 1562-7
  • 11 Choudhry AE, Mandichak TL, Broskey JP, Egolf RW, Kinsland C, Begley TP et al. Inhibitors of Pantothenate Kinase: Novel Antibiotics for Staphylococcal Infections. Antimicrob Agents Chemother. 2003; 47: 2051-5
  • 12 Colca JR, McDonal WG, Waldon DJ, Thomasco LM, Gadwood RC, Lund ET et al. Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics. J Biol Chem. 2003; 278: 21972-9
  • 13 Oliva B, Miller K, Caggiano N, O’Neill AJ, Cuny GD, Hoemann MZ et al. Biological Properties of Novel Antistaphylococcal Quinoline-Indole Agents. Antimicrob Agents Chemother. 2003; 47: 458-66
  • 14 Nasr MN, Gineinah MM, El-Bendary ER. synthesis and in vitro antibacterial evaluation of novel imidazo[2’,l’:5,l]-l,2,4-triazolo[4,3-c]-quinazoline derivatives of 5-thioxo-1,2,4-triazole, 4-oxothiazolidine, and their open-chain counterparts. Arch Pharm. 2003; 336: 560-6
  • 15 DeLima MCA, Costa DLB, Goes AJS, Galdino SL, Pitta IR, Luu-Duc C. Synthèse et activité antimicrobienne de dérivès chlorobenzyl benzylidène imidazolidinediones et thiazolidinediones substituées. Pharmazie. 1992; 47: 182-4
  • 16 Labouta IM, Salama HM, Eshba NH, Kader O, El-Chrbini E. Potential anti-microbial: syntheses and in vitro anti-microbial evaluation of some 5-arylazo-thiazolidones and related compounds. Eur J Med Chem. 1987; 22 (6) 485-9
  • 17 Metzger JV. Chemistry of hetero-cyclic compounds: thiazole and its derivatives. A series of monographs. vol. 34. Chichester: Wiley; 1979
  • 18 Rostom SAF, El-Ashmawy IM, Abd El Razik HA, Badr MH, Ashour HMA. Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents. Bioorg Med Chem. 2009; 17: 882-95
  • 19 Agarwal N, Kumar S, Srivastava AK, Sarkar PC. Synthesis and biological evaluation of some 2-amino-4-arylthiazoles and their N-aroyl derivatives. Ind J Het Chem. 1997; 6: 291-4
  • 20 Wilson KJ, Utig CR, Subhasinghe N, Hoffman JB, Rudolph NJ, Soll R et al. Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors. Bioorg Med Chem Lett. 2001; 11: 915-8
  • 21 Aher NG, Pore VS, Mishra NN, Kumar A, Shukla PK, Sharma A et al. Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues. Bioorg Med Chem Lett. 2009; 19 (3) 759-63
  • 22 Tehranchian S, Akbarzadeh T, Fazeli MR, Jamalifar H, Shafiee A. Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-di-hydrobenzo[c]thiophen-4(5H)ones. Bioorg Med Chem Lett. 2005; 15: 1023-5
  • 23 Ceylan-Ünlüsoy M, Bozdağ-Dündar O, Altanlar N, Ertan R. Synthesis and antimicrobial activity of some new 3-substituted benzyl-5-(4-chloro-2-piperidin-1yl-thiazole-5-yl-methylene)-thiazolidine-2,4-dione derivatives. Turkish J Chem. 2006; 30: 355-60
  • 24 Bozdağ-Dündar O, Özgen Ö, Menteşe A, Altanlar N, Atli O, Kendi E et al. Synthesis and antimicrobial activity of some new thiazolyl-thiazolidine-2,4-dione derivatives. Bioorg Med Chem. 2007; 15: 6012-7
  • 25 Bozdağ-Dündar O, Menteşe A, Verspohl EJ. Synthesis and antidiabetic activity of some new thiazolyl-2,4-thiazolidi-nediones. Arzneimittelforschung. 2008; 58: 131-5
  • 26 Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotics susceptibility testing by a standardized single disk method. Am Clin Pathol. 1966; 45: 493-6
  • 27 Athmani S, Farhat MF, Iddon B. Azoles. Part 9. Synthesis of derivatives of thieno[2,3-d]thiazole, 4H-pyrrolo[2,3-d]thiazole, 2H-pyrazolo[3,4-d]thiazole and isoxazolo[3,4-d]thiazole from thiazolidine-2,4-dione. J Chem Soc Perkin Trans. 1992; 1: 973-7
  • 28 Chebabe D, Dermaj A, Chikh ZAA, Hajjaji N, Rico-Lattes I, Lattes A. synthesis of new surfactants mono and bipolar derived from l,2,4-triazole-5-thione. Synthetic Commun. 2004; 34: 4189-98
  • 29 Bruno G, Costantino L, Curinga C, Maccari R, Monforte F, Nicolo F et al. Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. Bioorg. Med. Chem. 2002; 10: 1077-84
  • 30 Ishida T, In Y, Inoue M, Tanaka C, Hamanaka N. Conformation of (Z)-3-carboxymethyl-[(2E)-2-methyl-3-phenyl-propenylidene]rhodanine (epalrestat), a potent aldose reductase inhibitor: X-ray crystallographic, energy calculational, and nuclear magnetic resonance studies. J Chem Soc Perkin Trans 2. 1990; 2: 1085-91